CN Stock MarketDetailed Quotes

300026 Tianjin Chase Sun Pharmaceutical

Watchlist
  • 4.33
  • +0.01+0.23%
Market Closed Nov 8 15:00 CST
13.01BMarket Cap78.73P/E (TTM)

Tianjin Chase Sun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tianjin Chase Sun Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/FY -- / 6.511B --
-- 2024/FY -- / 6.194B --
-- 2023/FY 6.127B / 6.672B --
-- 2022/FY 6.650B / 6.758B --
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 6.511B--
--2024/FY-- / 6.194B--
--2023/FY6.127B / 6.672B--
--2022/FY6.650B / 6.758B--
--------

Unlock Free Earnings Estimates

Tianjin Chase Sun Pharmaceutical Earnings Reports

  • Hongri Pharmaceutical: Report for the third quarter of 2024

    Oct 25 00:00

  • Hongri Pharmaceutical: 2024 Semi-Annual Report

    Aug 30 00:00

  • Hongri Pharmaceutical: 2024 Semi-Annual Report Summary

    Aug 30 00:00

  • Tianjin Chase Sun Pharmaceutical: 2024 First Quarter Report

    Apr 26 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 10, 2024

    Buy

    • Strong Buy

      0.00%

    • Buy

      100.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data